We found that the tumor volume and weight were inhibited with the overexpression of RPS6KA2 in OVCAR3 group and promoted with the knockdown of RPS6KA2 in SKOV3 group (Figures 3A–C). Here, RPS6KA2 is linked to neoplasm.